Liang Li, Ph.D. Lecturer
Department of Pharmaceutics,
School of Pharmaceutical Sciences,
Peking University,
XueYuan Rd 38, Haidian Dist,
Beijing, 100191, P.R.China
Tel: 86-10-82805763
E-mail: liliang@bjmu.edu.cn
Liang Li, instructor in the Department of Pharmaceutics, School of Pharmacetical Science, Peking University Health Science Center since Aguest 2011. He received his Bachelor, Master and Ph.D. degree from School of Pharmaceutical Science, Peking University supervised by Prof. Wei Lu and Prof. Tianyan Zhou in 2006, 2008 and 2011, respectively. His Ph.D. program was supported by Pfizer Scholarship from Peking University/Pfizer Pharmacometrics Education Center.
Research Interests
l Population Pharmacokinetics
l Mechanism-based Pharmacokinetic/Pharmacodynamic modeling and simulation
Recent Publications
1. Li, Liang; Li, Zaiquan; Deng,Chenhui; Ning, Miaoran; Li, Hanqing; Bi, Shanshan; Zhou, Tianyan* and Lu, Wei*. Mechanism-based Pharmacokinetic/Pharmacodynamic Model for CYP3A1/2 Induction by Dexamethasone in Rats. Acta Pharmacologica Sinica, (2011), accepted
2. Liang LI, Zai-quan LI, Han-qing LI, Shan-shan BI, Chen-hui DENG, Jiao-jiao Xu, Tian-yan ZHOU* and Wei LU*. Development of Quantitative Real-time PCR Assays for Detection and Quantification of CYP3A1 and CYP3A2 mRNA in rat liver. J Chin Pharmaceu Sci, (2011), accepted.
3. Li, HanQing; Li, MengYao; Li, ZaiQuan; Li, Liang; Bi, ShanShan; Deng, ChenHui; Chen, Rui; Zhou,TianYan* and Lu, Wei*. New synthetic route of two active isomeric metabolites of erlotinib and their bioactivity studies against several tumor cell lines. Chinese Journal of Chemistry, (2011), 29(8), 1709-1714.
4. HanQing Li, MengYao Li, ZaiQuan Li, Liang Li, ShanShan Bi, ChenHui Deng, Rui Chen, TianYan Zhou*and Wei Lu*. New synthetic route of two active isomeric metabolites of erlotinib and their bioactivity studies against several tumor cell lines. Chin. J. Chem. (2011), accepted.
5. Wen-qian Chen, Yu-hui Hu, Yan-qing Zhang, Guan-min Zhang, Liang Li, Tian-yan Zhou*, Wei Lu*. Pharmacokinetic and pharmacodynamic study of paeoniflorin based on Guanxin II Prescription. Journal of Asian Natural Products Reasearch. (2011), accepted.
